KaLy-Cell in France
E-mail: l.richert@kaly-cell.com
Web: https://www.gba-group.com/en/pharma/kaly-cell
Services Provided:- In-vitro screening for CYP induction
- In-vitro regulatory (FDA/EMA) CYP and UGT induction
- In-vitro metabolic Stability & Metabolite Identification
- In-vitro/Ex-vivo Acute/Chronic Liver-related Toxicities
- In-vitro/Ex-vivo Drug induced liver injury
Address:
-
Office in Plobsheim
20a Rue du Général Leclerc 67115 Plobsheim, France
Phone: +33 3 88 10 88 30
Fax: +333 88 43 56 71
Clinical Trials sponsored by KaLy-Cell
-
Cell GenesysVoltooid
-
Cell GenesysVoltooid
-
Cell GenesysBeëindigdProstaatkankerVerenigde Staten, Frankrijk, België, Canada, Verenigd Koninkrijk, Zweden, Nederland, Duitsland
-
Cell GenesysOnbekendCarcinoom, overgangscel | Blaas neoplasmataVerenigde Staten, Canada
-
Cell GenesysVoltooidCarcinoom, niet-kleincellige long | Longkanker
-
Cell GenesysVoltooidProstaatkankerVerenigde Staten
-
Cell GenesysVoltooidMultipel myeloomVerenigde Staten
-
Cell GenesysVoltooidUitgezaaide alvleesklierkanker | Niet-reseceerbare alvleesklierkankerVerenigde Staten
About KaLy-Cell
KaLy-Cell has been developing its expertise in in vitro ADME-Toxicology with hepatocytes for almost 20 years.
Our services deliver informations with hepatocytes and/or liver subcellular fractions to evaluate inter-species differences and inter-individual variability in safety and drug efficacy, and to explain adverse reactions. The information is helping in optimizing the discovery, development and approval of drugs, food additives, agrochemicals and nutraceuticals.
KaLy-Cell is actively involved in innovative research in hepatocyte cell biology and in-vitro toxicology. In addition to standard protocol-driven studies we also offer consultation service experience and customized studies. In support of this type of research, we offer liver cellular products from animal and human origin.